Skip Navigation LinksHome > December 2012 - Volume 112 - Issue 12 > New Four-In-One Anti-HIV Drug
AJN, American Journal of Nursing:
doi: 10.1097/01.NAJ.0000423499.30770.fe
Drug Watch

New Four-In-One Anti-HIV Drug

Aschenbrenner, Diane S. MS, RN

Collapse Box


* Stribild, a new combination anti-HIV drug, has been approved by the Food and Drug Administration. The product contains two new drugs, elvitegravir and cobicistat, and two previously approved drugs, emtricitabine and tenofovir.

* Given once daily to treatment-naïve patients with HIV-1, Stribild is considered a complete treatment for HIV. This decreases the pill burden and should aid in promoting treatment adherence.

* Stribild's label carries boxed warnings similar to the labels of some other HIV drugs.

© 2012 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics